Algae Health announces AstaZine is now Non-GMO Project Verified

Algae Health Sciences, a subsidiary of BGG, announced its flagship AstaZine Natural Astaxanthin supercritical CO2 oleoresin extracts produced in Germany and whole-food based Astaxanthin-rich algae powder have attained Non-GMO Project Verified status

In conjunction with becoming the world’s first organically certified Haematococcus pluvialis microalgae product in March 2016 and bearing the NAXA Verified Seal, AstaZine has now become the clear choice for brands concerned with having the highest-quality third-party audited Astaxanthin raw materials in their finished products.

“The Non-GMO Project Verification seal is known and trusted in the US market and around the world,” said Joe Huff, CEO of AlgaeHealth’s North American operations. “We are happy to now offer this additional third-party certification to brands incorporating our AstaZine.”

AlgaeHealth’s AstaZine continues an industry-leading trajectory of regulatory and quality achievements in the last two years, including:

  • the first Astaxanthin NDI notification with the US FDA over 12 mg per day (at 24 mg per day)
  • the first company to gain two Novel Food Approvals in the EU for different Astaxanthin extraction methods
  • submission of 239 Structure/Function claims for Astaxanthin to FDA without objection
  • the world’s first organically certified Haematococcus pluvialis product.

AlgaeHealth produces AstaZine in a 100% glass tube photobioreactor (PBR) closed system on the world’s second largest Natural Astaxanthin farm.

AlgaeHealth produces AstaZine in a variety of forms including organically certified Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; and 2.5% microencapsulated beadlets.

Companies